Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.

Aikawa E, Kawahara A, Hattori S, Yamaguchi T, Abe H, Taira T, Azuma K, Kage M.

Cancer Cytopathol. 2011 Oct 25;119(5):335-45. doi: 10.1002/cncy.20162. Epub 2011 Jun 29.

2.

p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.

Nobre AR, Albergaria A, Schmitt F.

Acta Cytol. 2013;57(1):1-8. doi: 10.1159/000345245. Epub 2012 Dec 6. Review.

3.

Napsin A expression in lung and kidney neoplasia: a review and update.

Ordóñez NG.

Adv Anat Pathol. 2012 Jan;19(1):66-73. doi: 10.1097/PAP.0b013e31823e472e. Review.

PMID:
22156835
4.

Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice.

Rossi G, Pelosi G, Barbareschi M, Graziano P, Cavazza A, Papotti M.

Int J Surg Pathol. 2013 Aug;21(4):326-36. doi: 10.1177/1066896913489346. Epub 2013 Jun 5. Review.

PMID:
23740564
5.

Lung cancer samples preserved in liquid medium: One step beyond cytology.

Mariano VS, Leal LF, Pastrez PRA, Silva EM, Reis RM, Longatto-Filho A.

Diagn Cytopathol. 2017 Oct;45(10):915-921. doi: 10.1002/dc.23743. Epub 2017 Jun 6. Review.

PMID:
28589673

Supplemental Content

Support Center